These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28811010)

  • 1. Distinct clinical characteristics of paroxysmal nocturnal hemoglobinuria in patients in Southern Taiwan: A multicenter investigation.
    Wang HC; Kuo CY; Liu IT; Chen TY; Chang YH; Lin SJ; Cho SF; Liu YC; Liu TC; Lin SF; Chang CS
    Kaohsiung J Med Sci; 2017 Aug; 33(8):405-410. PubMed ID: 28811010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
    Jang JH; Kim JS; Yoon SS; Lee JH; Kim YK; Jo DY; Chung J; Sohn SK; Lee JW
    J Korean Med Sci; 2016 Feb; 31(2):214-21. PubMed ID: 26839475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
    Schrezenmeier H; Röth A; Araten DJ; Kanakura Y; Larratt L; Shammo JM; Wilson A; Shayan G; Maciejewski JP
    Ann Hematol; 2020 Jul; 99(7):1505-1514. PubMed ID: 32390114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
    Raza A; Ravandi F; Rastogi A; Bubis J; Lim SH; Weitz I; Castro-Malaspina H; Galili N; Jawde RA; Illingworth A
    Cytometry B Clin Cytom; 2014 May; 86(3):175-82. PubMed ID: 24227693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.
    Villegas A; Núñez R; Gaya A; Cuevas-Ruiz MV; Bosch JM; Carral A; Arrizabalaga B; Gómez-Roncero MI; Mora A; Bravo P; Lavilla E; Monteserín C; Hernández B; Martínez-Barranco P; Jarque I; Urquía MA; García-Donas G; Brunet S; González FA; Urbano Á
    Ann Hematol; 2017 Oct; 96(10):1727-1733. PubMed ID: 28748287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
    Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of paroxysmal nocturnal hemoglobinuria in pediatric and adolescent patients.
    Mercuri A; Farruggia P; Timeus F; Lombardi L; Onofrillo D; Putti MC; Pillon M; Cantarini ME; Corti P; Tridello G; De Bortoli M; Pegoraro A; Cesaro S
    Blood Cells Mol Dis; 2017 May; 64():45-50. PubMed ID: 28380398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Füreder W; Sperr WR; Heibl S; Zebisch A; Pfeilstöcker M; Stefanzl G; Jäger E; Greiner G; Schwarzinger I; Kundi M; Keil F; Hoermann G; Bettelheim P; Valent P
    Ann Hematol; 2020 Oct; 99(10):2303-2313. PubMed ID: 32856141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation with alpha/beta T-lymphocyte depletion and short course of eculizumab in adolescents and young adults with paroxysmal nocturnal hemoglobinuria.
    Shasheleva DA; Maschan AA; Shelikhova LN; Petrova UN; Kurnikova EE; Illarionova OI; Boyakova EV; Novichkova GA; Maschan MA
    Ter Arkh; 2018 Aug; 90(7):57-64. PubMed ID: 30701923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab: The role of hepatocanalicular transporter variants.
    Alashkar F; Weber SN; Vance C; Herich-Terhürne D; Dührsen U; Lammert F; Röth A
    Eur J Haematol; 2017 Oct; 99(4):350-356. PubMed ID: 28692147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.
    Pu JJ; Mukhina G; Wang H; Savage WJ; Brodsky RA
    Eur J Haematol; 2011 Jul; 87(1):37-45. PubMed ID: 21447004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.
    Kim JS; Jang JH; Jo DY; Ahn SY; Yoon SS; Lee JH; Kim SH; Choi CW; Shin HJ; Kim MK; Lee JH; Mun YC; Kong JH; Hyun B; Nam H; Kim E; Kwak MJ; Won YK; Lee JW
    J Korean Med Sci; 2023 Oct; 38(41):e328. PubMed ID: 37873628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry.
    Dingli D; Maciejewski JP; Larratt L; Go RS; Höchsmann B; Zu K; Gustovic P; Kulagin AD
    Ann Hematol; 2023 Jul; 102(7):1637-1644. PubMed ID: 37199789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry.
    Almeida AM; Bedrosian C; Cole A; Muus P; Schrezenmeier H; Szer J; Rosse WF
    Intern Med J; 2017 Sep; 47(9):1026-1034. PubMed ID: 28608499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab].
    Nishimura JI
    Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
    Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
    Goren Sahin D; Akay OM; Keklik M; Okan V; Karakus A; Demir C; Erkurt MA; Ilkkilic K; Yildirim R; Akgun Cagliyan G; Aksu S; Dogu MH; Dal MS; Karakus V; Gemici AI; Terzi H; Kelkitli E; Sivgin S; Unal A; Yilmaz M; Ayyildiz O; Korkmaz S; Eser B; Altuntas F
    Ann Hematol; 2021 Jul; 100(7):1667-1675. PubMed ID: 33988739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.
    Schrezenmeier H; Muus P; Socié G; Szer J; Urbano-Ispizua A; Maciejewski JP; Brodsky RA; Bessler M; Kanakura Y; Rosse W; Khursigara G; Bedrosian C; Hillmen P
    Haematologica; 2014 May; 99(5):922-9. PubMed ID: 24488565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry.
    Jang JH; Kim JS; Lim CTK; Kleinman NJ; Myren KJ; Wang A; Patel Y; Lee JW
    J Korean Med Sci; 2024 Mar; 39(8):e81. PubMed ID: 38442722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.